<?xml version="1.0" encoding="UTF-8"?>
<p>The bioactive compound was tested for antimicrobial activities against three Gram-positive bacteria, 
 <italic>B. subtilis</italic> (UBC 344), 
 <italic>S. aureus</italic> (ATCC 43300) and MRSA (ATCC 33591), two Gram-negative bacteria, 
 <italic>E. coli</italic> (UBC 8161), 
 <italic>P. aeruginosa</italic> (ATCC 27853) and the pathogenic fungus 
 <italic>C. albicans</italic> (ATCC 90028). The minimum inhibitory concentrations (MICs) were determined using broth micro-dilution method according to National Committee for Clinical Laboratory Standards with modification using Mueller Hinton broth as the medium [
 <xref ref-type="bibr" rid="CR19">19</xref>]. The commercial antimicrobial agents polymyxin B, rifamycin and amphotericin were used as positive controls.
</p>
